Department of Clinical Laboratory, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
The AoYang Cancer Research Institute of Jiangsu University, Zhangjiagang, Suzhou, Jiangsu, China.
Cancer Biomark. 2022;33(1):123-129. doi: 10.3233/CBM-210178.
Gastric adenocarcinoma (GAC) is one of the most common malignancies. Increasing data have indicated a correlation between soluble B7-H3 (sB7-H3) levels and tumor malignancies. In this study, we aim to investigate the level of soluble B7-H3 in serum of GAC patients. Further, we analyze the correlation between sB7-H3 level and tissue B7-H3 expression and explore the clinical evaluation value of sB7-H3 associated with pathological characteristics and prognosis of GAC patients.
One hundred and twenty-eight serum and tissue samples of GAC, 20 serum and tissue samples of gastritis patients and 77 serum, 5 tissue samples of healthy controls were collected. The serum levels of sB7-H3 were detected by Enzyme-linked immunosorbent assay (ELISA), while the expression of membrane B7-H3 (mB7-H3) and Ki67 were evaluated by immunohistochemistry. The correlation between sB7-H3 and mB7-H3, sB7-H3 and Ki67, sB7-H3 or mB7-H3 and clinical features were analyzed by Pearson's Chi-square test.
Both serum level of sB7-H3 and tissue B7-H3 of GAC patients were significantly higher than those of gastritis patients and healthy controls. sB7-H3 level was correlated with total B7-H3 expression in tissues (r= 0.2801, P= 0.0014). Notably, the concentration of sB7-H3 was correlated with its expression of membrane form in tumor cells (r= 0.3251, P= 0.002) while not in stromal cells (r= 0.07676, P= 0.3891). Moreover, the levels of sB7-H3 in patients with TNM stage III/IV or with infiltration depth T3/T4 or with lymph node metastasis were significantly higher than those of patients with TNM stage I/II (P= 0.0020) or with Infiltration depth T1/T2 (P= 0.0169) or with no lymph node metastasis (P= 0.0086). Tumor B7-H3 score, but not stromal B7-H3 score, in patients with TNM stage III/IV or with lymph node metastasis was significantly higher than those with TNM stage I/II (P= 0.0150) or with no lymph node metastasis (P= 0.182).
Soluble B7-H3 level may reflect the tissue B7-H3 expression on tumor cells of GAC tissues. Elevated level of sB7-H3 in serum suggests poor clinical pathological characteristics of GAC patients.
胃腺癌(GAC)是最常见的恶性肿瘤之一。越来越多的数据表明,可溶性 B7-H3(sB7-H3)水平与肿瘤恶性程度之间存在相关性。本研究旨在检测 GAC 患者血清中可溶性 B7-H3 的水平。进一步分析 sB7-H3 水平与组织 B7-H3 表达之间的相关性,并探讨 sB7-H3 与 GAC 患者病理特征和预后的临床评估价值。
收集 128 例 GAC 患者血清和组织样本、20 例胃炎患者血清和组织样本、77 例健康对照者血清和 5 例组织样本。采用酶联免疫吸附试验(ELISA)检测血清 sB7-H3 水平,免疫组织化学法检测膜型 B7-H3(mB7-H3)和 Ki67 的表达。采用 Pearson 卡方检验分析 sB7-H3 与 mB7-H3、sB7-H3 与 Ki67、sB7-H3 或 mB7-H3 与临床特征之间的相关性。
GAC 患者血清 sB7-H3 水平和组织 B7-H3 水平均明显高于胃炎患者和健康对照组。sB7-H3 水平与组织中总 B7-H3 表达呈正相关(r=0.2801,P=0.0014)。值得注意的是,sB7-H3 浓度与肿瘤细胞中膜型表达呈正相关(r=0.3251,P=0.002),而与基质细胞中膜型表达无相关性(r=0.07676,P=0.3891)。此外,TNM 分期为 III/IV 期或浸润深度 T3/T4 或有淋巴结转移的患者 sB7-H3 水平明显高于 TNM 分期为 I/II 期(P=0.0020)或浸润深度为 T1/T2 期(P=0.0169)或无淋巴结转移的患者(P=0.0086)。TNM 分期为 III/IV 期或有淋巴结转移的患者肿瘤 B7-H3 评分明显高于 TNM 分期为 I/II 期(P=0.0150)或无淋巴结转移的患者(P=0.182),而基质 B7-H3 评分无显著差异。
血清 sB7-H3 水平可能反映 GAC 组织中肿瘤细胞的组织 B7-H3 表达。血清 sB7-H3 水平升高提示 GAC 患者临床病理特征较差。